Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Country |
Opioids |
% inj |
Cocaine |
% inj |
Amphet- |
% inj |
Ecstasy |
Hallucin- |
% inj |
Cannabis |
Others | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Belgium |
(1) |
33.2 |
37.7 |
6.0 |
11.0 |
12.0 |
6.0 |
1.0 |
0.0 |
|
15.0 |
32.8 |
Czech Republic |
|
24.5 |
86.4 |
0.2 |
16.7 |
54.2 |
84.9 |
0.4 |
0.2 |
0.0 |
16.5 |
4.0 |
Denmark |
|
47.2 |
19.3 |
4.8 |
9.2 |
6.5 |
4.6 |
1.0 |
0.0 |
|
26.8 |
13.7 |
Germany |
(2) |
52.3 |
|
5.9 |
|
6.0 |
|
|
0.2 |
|
30.2 |
5.4 |
Greece |
|
88.7 |
49.8 |
2.2 |
7.4 |
0.1 |
0.0 |
0.3 |
0.1 |
0.0 |
7.0 |
1.6 |
Spain |
(3) |
59.0 |
24.0 |
26.0 |
9.0 |
1.0 |
9.0 |
1.0 |
0.1 |
14.0 |
11.0 |
1.9 |
France |
(4) |
70.6 |
|
5.8 |
|
0.3 |
|
1.1 |
0.3 |
|
17.6 |
4.3 |
Ireland |
(5) |
59.1 |
57.8 |
5.3 |
12.8 |
0.7 |
2.9 |
4.4 |
0.1 |
0.0 |
27.7 |
2.7 |
Italy |
|
73.4 |
41.0 |
9.2 |
5.0 |
0.1 |
0.0 |
0.7 |
0.1 |
12.0 |
13.2 |
3.3 |
Cyprus |
|
66.7 |
79.5 |
8.9 |
0.0 |
0.0 |
|
2.9 |
0.2 |
0.0 |
20.8 |
0.5 |
Latvia |
|
52.6 |
83.9 |
0.8 |
25.0 |
12.0 |
63.9 |
1.4 |
1.8 |
0.0 |
3.3 |
28.1 |
Lithuania |
(6) |
79.0 |
|
0.1 |
|
2.4 |
|
|
0.2 |
|
1.0 |
17.3 |
Luxembourg |
|
79.0 |
70.0 |
11.0 |
58.0 |
0.6 |
|
1.4 |
0.3 |
|
5.4 |
2.3 |
Hungary |
|
14.4 |
71.0 |
0.8 |
14.2 |
4.1 |
20.9 |
3.1 |
0.5 |
0.0 |
32.3 |
44.8 |
Malta |
|
83.5 |
73.6 |
5.8 |
15.2 |
0.2 |
|
2.9 |
0.2 |
|
7.4 |
0.0 |
Netherlands |
|
29.4 |
9.5 |
36.6 |
0.9 |
4.1 |
2.9 |
1.1 |
0.8 |
2.7 |
24.9 |
3.1 |
Austria |
(7) |
100.0 |
100.0 |
0.0 |
|
0.0 |
|
0.0 |
0.0 |
|
0.0 |
0.0 |
Poland |
(8) |
23.3 |
|
0.9 |
|
8.9 |
|
|
0.6 |
|
3.0 |
63.3 |
Portugal |
(9) |
|
|
|
|
|
|
|
|
|
|
|
Slovenia |
(10) |
84.6 |
71.5 |
1.7 |
31.6 |
0.2 |
0.0 |
0.5 |
0.0 |
|
12.7 |
0.4 |
Slovakia |
|
42.6 |
77.4 |
0.5 |
0.2 |
24.7 |
40.6 |
0.2 |
0.8 |
5.5 |
17.2 |
14.1 |
Finland |
|
39.0 |
84.8 |
0.1 |
|
30.4 |
78.2 |
0.4 |
0.1 |
|
20.4 |
9.6 |
Sweden |
|
31.5 |
63.7 |
2.1 |
3.3 |
35.0 |
58.9 |
0.5 |
0.1 |
0.0 |
19.5 |
11.3 |
United Kingdom |
(11) |
71.0 |
51.0 |
9.0 |
7.0 |
3.5 |
33.0 |
0.8 |
0.1 |
13.0 |
11.0 |
4.6 |
Bulgaria |
|
95.9 |
79.6 |
0.1 |
0.0 |
0.3 |
0.0 |
0.1 |
0.0 |
|
2.8 |
0.8 |
Romania |
|
55.3 |
82.0 |
0.2 |
0.0 |
0.2 |
0.0 |
0.5 |
0.2 |
0.0 |
15.1 |
28.5 |
Turkey |
|
43.6 |
19.8 |
4.7 |
0.1 |
0.0 |
|
6.3 |
0.0 |
|
22.6 |
22.8 |
Notes: Data are not available for: Estonia, Norway. Injecting as a route of administration is not reported for ecstasy, cannabis and other drugs. When proportion of clients by main drug is 0, % of injectors is empty. (1) Last data available refer to 1999. (2) Data on amphetamines include amphetamines and ecstasy. Data on injection not available. Data taken from ST.04. (3) Last data available refer to 2002. (4) Data on treatment demand referred to the annual census on clients in treatment carried out in November 2003. (5) Last data available refer to 2003. (6) Data on amphetamines include amphetamines and ecstasy. (7) Data refer to clients in substitution treatment only; figures for opiates as main drug and injecting use are 100 %. (8) Last data available refer to 2003. Amphetamines include amphetamines + ecstasy. (9) The total number of clients is available for 2003. No data available for 2004. (10) Data refer to outpatient treatment centres and prison. (11) Data relate to the period from 1 April 2003 to 31 March 2004 for UK. See also 'General notes for interpreting data' on the Explanatory notes and help page. Sources: 2005 Reitox national reports - Standard Table 3 (see Table TDI-1 for details on sources) | ||||||||||||